Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

Description

The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.

Conditions

Pulmonary Fibrosis

Talk to us

Study Overview

On this page

Study Details

Study overview

The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

Condition
Pulmonary Fibrosis
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

University of Pittsburgh, Pittsburgh, Pennsylvania, United States, 15213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age or older
  • * Diagnosis of pulmonary fibrosis confirmed by physical examination, pulmonary function testing, chest X-ray, and computed tomography (CT) scans.
  • * Adult patients who are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease.
  • * Under 18 years of age
  • * Non-fibrotic ILD

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pittsburgh,

Kevin F Gibson, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh, Simmons Center for ILD

Study Record Dates

2035-07